Results 171 to 180 of about 83,183 (296)
Song et al. developed an mGM‐CSF‐loaded, liver cancer cell‐based vaccine that potently activated dendritic cells and elicited tumour‐specific T cell responses. Mechanistically, radiation‐induced oxidative damage to mitochondrial DNA in cancer cells triggers the cGAS‐STING pathway in DCs, which synergizes with mGM‐CSF‐driven JAK2‐STAT3 signalling to ...
Zhiruo Song +15 more
wiley +1 more source
T-cell receptor insights: Determinants of Major Histocompatibility Complex class I versus class II recognition. [PDF]
De Almeida Mendes M +5 more
europepmc +1 more source
Impact of G‐CSF on Donor TCR Clonal Diversity and T Cell Function During Donor HSC Mobilisation
In this study, we found that G‐CSF mobilisation caused a reduction in TCR clonal diversity and down‐regulation of T‐cell function in donors. This may be one of the reasons for the low incidence of GVHD mediated by G‐CSF after allo‐HSCT. Source: Created in BioRender. Li https://BioRender.com/otownki.
Xinye Li +14 more
wiley +1 more source
Case Report: A novel CIITA mutation causing MHC class II deficiency: first reported case in Morocco. [PDF]
Kattra AB +9 more
europepmc +1 more source
ABSTRACT Background Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease marked by the destruction of pancreatic β‐cells, resulting in lifelong dependence on exogenous insulin. Despite advances in insulin delivery and glucose monitoring technologies, patients remain at risk for acute and long‐term complications, underscoring the need for ...
Tzu‐Min Lin +5 more
wiley +1 more source
Four Novel HLA-B and HLA-C Alleles Identified in Brazilian Individuals. [PDF]
Fabreti-Oliveira RA +2 more
europepmc +1 more source
Immunological Tolerance: One of Biology's Most Intriguing Mysteries [PDF]
Bach FH +48 more
core +1 more source
ABSTRACT Minimal residual disease (MRD) has emerged as a central biomarker in hematologic malignancies, enabling highly sensitive detection of tumor persistence beyond conventional morphologic assessment and serving as an increasingly important surrogate endpoint in clinical trials.
Santino Caserta +14 more
wiley +1 more source
Clustering-based identification of immune-related gene signatures in hepatocellular carcinoma. [PDF]
Brahmaiah J +3 more
europepmc +1 more source

